Page 7 - Sergio Traversa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry

/PRNewswire/ Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today.

United statesPaolol manfrediSergio traversaTim mccarthyRelmada therapeutics incClinical research programTherapeutics incDepartment of psychiatry at massachusettsSecurities exchangeRelmada therapeuticsAmerican journalAdjunctive treatmentMajor depressive disorderDouble blind randomized trialChief scientific officerAsberg depression scale

FinancialNewsMedia com: Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression

PALM BEACH, Fla., Nov. 23, 2021 /PRNewswire/ FinancialNewsMedia.com News Commentary - The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant

United statesCity ofUnited kingdomYassine bendiabdallahPrnewswire financialnewsmediaKim kuypersKostenloser wertpapierhandelTiago reis marquesSergio traversaRyan wattsDenali therapeutics incVoyager therapeutics incMaastricht universityMental health services administrationKaiser family foundationFn media group

Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression

/PRNewswire/ FinancialNewsMedia.com News Commentary - The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global.

United statesCity ofUnited kingdomYassine bendiabdallahPrnewswire financialnewsmediaKim kuypersTiago reis marquesSergio traversaRyan wattsDenali therapeutics incVoyager therapeutics incMaastricht universityMental health services administrationKaiser family foundationFn media groupExchange commission

Relmada Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

Relmada Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Tim mccarthySergio traversaClinical research programRelmada therapeutics incOppenheimer fall healthcare life sciencesSecurities exchangeRelmada therapeuticsChief executive officerMedtech summitResearch programPrivate securities litigation reform actSecurities actSecurities exchange actSci advisorsநேரம் ம்க்கார்தீமருத்துவ ஆராய்ச்சி ப்ரோக்ர்யாம்

Relmada Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Relmada Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Tim mccarthySergio traversaClinical research programRelmada therapeutics incSecurities exchangeRelmada therapeuticsChief executive officerResearch programPrivate securities litigation reform actSecurities actSecurities exchange actSci advisors